Human Immunodeficiency Virus (HIV) Diagnosis Market Poised for Growth, Expected to Reach $6.42 Billion by 2028

Human Immunodeficiency Virus (HIV) Diagnosis Market

Human Immunodeficiency Virus (HIV) Diagnosis Market Report 2024 – Market Size, Trends, And Forecast 2024-2033

The Business Research Company’s Human Immunodeficiency Virus (HIV) Diagnosis Global Market Report 2024 – Market Size, Trends, And Forecast 2024-2033

You Can Now Pre Order Your Report To Get A Swift Deliver With All Your Needs ”
— The Business Research Company

LONDON, GREATER LONDON, UK, June 20, 2024 /EINPresswire.com/ -- The HIV diagnosis market has witnessed rapid growth in recent years, with revenues expanding from $3.79 billion in 2023 to $4.2 billion in 2024, reflecting a compound annual growth rate (CAGR) of 11%. This growth trajectory can be attributed to the expansion of voluntary counseling and testing services, advancements in HIV antibody tests, the global impact of the HIV/AIDS epidemic, and community-led and peer-led initiatives.

Rising Blood Donation Drives Market Growth
The increasing prevalence of blood donation is anticipated to propel the HIV diagnosis market forward. Blood donation involves the voluntary collection of blood, which has seen enhanced participation due to improved medical technologies, community engagement efforts, and more effective donor recruitment strategies. Organizations like NHS Blood and Transplant have seen an uptick in new donors, contributing to a larger pool of blood samples available for HIV testing. This surge in blood donations enables more extensive screening for HIV antigens and antibodies, thereby enhancing the accuracy and reliability of HIV diagnoses.

Explore the global HIV diagnosis market with a detailed sample report:
https://www.thebusinessresearchcompany.com/sample_request?id=15587&type=smp

Major Players and Market Trends
Leading companies such as Thermo Fisher Scientific Inc., Abbott Laboratories, and Siemens Healthineers are focusing on advancing chip-based real-time PCR technologies for HIV detection. These innovations aim to improve testing accuracy, reduce turnaround times, and enhance accessibility across different healthcare settings. For example, Molbio Diagnostics recently launched the Truenat HIV-1 test, utilizing Taqman chemistry on microfluidic chips to quantify viral loads with high sensitivity and specificity.

Advancements in Testing Technologies
In the forecast period, significant trends include the adoption of targeted testing strategies and community-based testing and outreach initiatives. There is also a growing emphasis on equity, inclusivity, and policy-driven funding priorities to expand access to HIV diagnosis services globally.

Segments
•Product: Consumables, Instruments, Software and Services
•Mode: Self-Test, Lab-Based
•End User: Diagnostic Laboratories, Hospitals, Research Institutions

Geographical Insights: Asia-Pacific Leading the Market
North America held the largest share of the HIV diagnosis market in 2023, driven by advanced healthcare infrastructure and high awareness levels. However, Asia-Pacific is expected to emerge as the fastest-growing region during the forecast period, supported by increasing healthcare investments and rising awareness about HIV/AIDS.

Access the complete report for an in-depth analysis of the global HIV diagnosis market:
https://www.thebusinessresearchcompany.com/report/human-immunodeficiency-virus-hiv-diagnosis-global-market-report

Human Immunodeficiency Virus (HIV) Diagnosis Global Market Report 2024 from TBRC covers the following information:
•Market size data for the forecast period: Historical and Future
•Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
•Market analysis by countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Trends, opportunities, strategies and so much more.
The Human Immunodeficiency Virus (HIV) Diagnosis Global Market Report 2024 by The Business Research Company is the most comprehensive report that provides insights on human immunodeficiency virus (hiv) diagnosis market size, human immunodeficiency virus (hiv) diagnosis market drivers and trends, human immunodeficiency virus (hiv) diagnosis market major players, competitors' revenues, market positioning, and market growth across geographies. The human immunodeficiency virus (hiv) diagnosis market report helps you gain in-depth insights on opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential.

Browse Through More Similar Reports By The Business Research Company:
Immunohistochemistry (IHC) Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/immunohistochemistry-ihc-global-market-report

Immunohematology Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/immunohematology-global-market-report

Immunoglobulins Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/immunoglobulins-global-market-report

About The Business Research Company
The Business Research Company has published over 27 industries, spanning over 8000+ markets and 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Global Market Model – Market Intelligence Database
The Global Market Model, The Business Research Company’s flagship product, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets that help its users assess supply-demand gaps.

Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
X
LinkedIn